Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Hidradenitis Suppurativa Clinical Trials
Hidradenitis Suppurativa clinical trials are recruiting across 111 cities. Here are the cities with the most active studies:
Hidradenitis Suppurativa Trial Phases
35 research organizations are sponsoring hidradenitis suppurativa trials.
About Hidradenitis Suppurativa
Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.
Clinical trials are advancing new treatments for hidradenitis suppurativa. Currently, 44 studies are recruiting a combined 15,144 participants across the United States. Research is being conducted by 35 organizations including NYU Langone Health, University of California, San Francisco, Children's Hospital Medical Center, Cincinnati and 32 others.
2026 Hidradenitis Suppurativa Research Landscape
As of July 2026, the hidradenitis suppurativa clinical trial landscape includes 44 actively recruiting studies across 111 cities in the United States. These studies are collectively seeking 15,144 participants, with an average enrollment target of 344 per study.
The research spans multiple phases of development: 15 studies are in PHASE2, 6 studies are in PHASE3, 5 studies are in PHASE1, 5 studies are in NA, 3 studies are in EARLY_PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some hidradenitis suppurativa treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 35 different organizations, including NYU Langone Health, University of California, San Francisco, Children's Hospital Medical Center, Cincinnati, AbbVie, Incyte Corporation, and 30 others. The large number of sponsors reflects significant research interest and investment in hidradenitis suppurativa treatment advancement.
Geographically, hidradenitis suppurativa trials are most concentrated in Phoenix, Arizona (11 trials); Birmingham, Alabama (7 trials); Scottsdale, Arizona (7 trials); Miami, Florida (7 trials); Tampa, Florida (6 trials) and 7 other cities.
Featured Hidradenitis Suppurativa Studies
Highlighted recruiting studies for hidradenitis suppurativa, selected by enrollment size and research scope.
Hirschsprung Disease Genetic Study
Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis f...
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury includes diffuse alveolar hemorrhage (DAH), thrombotic microangiopathy (TMA) interstitial pneumonitis (IPS) and infection, while later, bronchiolitis obliterans is a complication of chronic GVHD associated with severe mo...
Frequently Asked Questions About Hidradenitis Suppurativa Clinical Trials
Are there hidradenitis suppurativa clinical trials near me?
Yes, there are 44 hidradenitis suppurativa clinical trials currently recruiting across 111+ cities in the United States, including Phoenix, Arizona; Birmingham, Alabama; Scottsdale, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a hidradenitis suppurativa clinical trial?
To join a hidradenitis suppurativa clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are hidradenitis suppurativa clinical trials free?
Yes, participation in hidradenitis suppurativa clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of hidradenitis suppurativa treatments are being studied?
Current hidradenitis suppurativa clinical trials are testing a range of approaches across PHASE2 (15 studies), PHASE3 (6 studies), PHASE1 (5 studies), NA (5 studies), EARLY_PHASE1 (3 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 35 research organizations.
Is it safe to participate in hidradenitis suppurativa clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov